Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis

Bone Marrow Transplantation

Volumn 20, Issue 2, 1997, Pages 107-112

  Michel, G ^a   Boulad, F ^a   Small, T N ^a   Black, P ^a   Heller, G ^a   Castro Malaspina, H ^a   Childs, B H ^a   Gillio, A P ^a   Papadopoulos, E B ^a   Young, J W ^a   Kernan, N A ^a   O'Reilly, R J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Acute myelogenous leukemia; Bone marrow transplant; Leukemia cutis

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HLA MATCHING; HUMAN; MALE; PRIORITY JOURNAL; RECURRENCE RISK; SKIN CANCER; SKIN LEUKEMIA;

EID: 0030788245     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700857     Document Type: Article

References (33)

1. Long JC, Mihn MD. Multiple granulocytic tumors of the skin, report of six cases of myelogeneous leukemia with initial manifestations in the skin. Cancer 1977; 39: 2004-2016.
2. Sun NCG, Ellis R. Granulocytic sarcoma of the skin. Arch Dermatol 1980; 116: 800-802.
3. Neiman RS, Barcos M, Berard C et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer 1981; 48: 1426-1437.
4. Su WPD, Buechner SA, Li CY. Clinicopathologic correlations in leukemia cutis. Am Acad Dermatol 1984; 11: 121-128.
5. Meis JM, Butler JJ, Osbone BM, Manning JT. Granulocytic sarcoma in nonleukemic patients. Cancer 1986; 58: 2697-2709.
6. Ohno S, Yokoo T, Ohta M et al. Aleukemic leukemia cutis. J Am Acad Dermatol 1990; 22: 374-377.
7. Resnik KS, Brod BB. Leukemia cutis in congenital leukemia. Analysis and review of the world literature with report of an additional case. Arch Dermatol 1993; 129: 1301-1306.
8. Su WPD. Clinical, histopathologic, and immunohistochemical correlations in leukemia cutis. Semin Dermatol 1994; 13: 223-230.
9. Keating MJ, Freireich EJ. Acute myelogeneous leukemia. In: Bick RL (ed). Hematology, Clinical and Laboratory Practice. Mosby: St Louis, 1993, pp 1161-1195.
10. Boggs DR, Wintrobe MM, Cartwright GE. The acute leukemias: analysis of 322 cases and review of the literature. Medicine 1962; 41: 163-225.
11. Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytie leukemia: a clinical review. J Clin Oncol 1995; 13: 1800-1816.
12. Tobelem G, Jacquillat C, Chastang C et al. Acute monoblastic leukemia: a clinical and biological study of 74 cases. Blood 1980; 55: 71-76.
13. Pui CH, Kalwinsky DK, Schell MJ et al. Acute nonlymphoblastic leukemia in infants: clinical presentation and outcome. J Clin Oncol 1988; 6: 1008-1013.
14. Baer MR, Barcos M, Farrell H et al. Acute myelogeneous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986. Cancer 1989; 63: 2192-2200.
15. Thompson CB, Sanders JE, Flournoy N et al. The risk of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia. Blood 1986; 67: 195-199.
16. Sanders JE, Flournoy N, Thomas E et al. Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse and graftversus-host disease. Med Ped Oncol 1985; 13: 165-172.
17. Shank B, Hopfan S, Kim JH et al. Hyperfractionated total body irradiation for bone marrow transplantation: early results in leukemia patients. Int J Radiat Oncol Biol Phys 1981; 7: 1109-1115.
18. Young JW, Papadopoulos EB, Cunningham I et al. T-cell depleted allogeneic bone marrow transplantation in adults with nonlymphocytic leukemia in first remission. Blood 1992; 79: 3380-3387.
19. Papadopoulos EB, Carabasi M, Young J et al. Results of T-cell depleted (TCD) allogeneic BMT after TBI. thiotepa and cyclophosphamide in patients with leukemia. Blood 1992; 80 (Suppl. 1): 170a.
20. 131I-M195/busulfan/cyclophosphamide in patients with advanced/refractory myeloid malignancies. Blood 1993; 82 (Suppl. 1): 80a.
21. Reisner Y, Kapoor N, Kirkpatrick D et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983; 61: 341-348.
22. Reisner Y, Kirkpatrick D, Dupont B et al. Transplantation for acute leukemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 1981; 2: 327-331.
23. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
24. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graftversus-host syndrome in man: a long-term clinico-pathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
25. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
26. Kalbfleisch JD, Prenctice RL. The Statistical Analysis of Failure Time Data. Wiley: New York, NY, 1980, p 163.
27. Wilcoxon F. Individual comparisons by ranking methods. Biometrics, 1945; 1: 80-83.
28. Tavassoli M, Hardy CL. Molecular basis of homing of intravenously transplanted stem cells to the marrow. Blood 1990; 76: 1059-1070.
29. Lanza F, Bi S, Castoldi G, Goldman JM. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia. Leukemia 1993; 7: 1570-1575.
30. Verfaillie CM, McCarthy JB, McGlave PB. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. J Clin Invest 1992; 90: 1232-1241.
31. De Rossi G, Zarcone D, Mauro F et al. Adhesion molecule expression on B-cell chronic lymphocytic leukemia cell phenotypes defines distinct disease subsets. Blood 1993; 81: 2679-2687.
32. Rubin CM, Arthur DC, Meyers G et al. Leukemia cutis treated with total skin irradiation. Cancer 1984; 55: 2649-2652.
33. Solberg LA, Wick MR, Bruckman JE. Doxorubicin enhanced skin reaction after whole-body electron beam irradiation for leukemia cutis. Mayo Clin Proc 1980; 55: 711-715.